ARTIDIS
ARTIDIS AG is a clinical-stage health technology company based in Basel, Switzerland. It specializes in nanotechnology for cancer diagnosis and personalized treatment optimization. Founded as a spin-off from the University of Basel, ARTIDIS has developed a nanomechanical analysis platform that measures the physical properties of cells and tissues at the nanoscale using Atomic Force Microscopy (AFM). The core product quantifies cell and tissue stiffness to provide rapid and precise cancer diagnoses, assess tumor aggressiveness, and predict therapy responses. This platform integrates various clinical data into the ARTIDISNet digital platform, enabling physicians to shorten diagnostic times and design personalized cancer treatment plans. The technology is AI-powered and clinically validated, applicable to any living tissue, and designed to integrate with existing standards of care. ARTIDIS is located within Technopark Basel, fostering collaboration with leading research institutions and pharmaceutical companies.
Work at ARTIDIS in HR or recruiting? Claim this page
Headcount trend
ARTIDIS went from 13 employees in Oct 2024 to 18 in Sep 2026. Apr to Sep 2026: 3 people joined, 0 left.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Oct 2020 | Seed | $15.1M | 1 | |
| Dec 2019 | Seed | $8.8M | 1 |
Org structure
Headcount by department
H-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 1 filings.
Peer reviews
Worked with someone at ARTIDIS?
Anonymous peer reviews on OffTheRecord
Hiring now
Similar companies
ARTIDIS FAQ
How many employees does ARTIDIS have?
ARTIDIS has about 18 employees, unchanged over the 3 months to Sep 2026.
Does ARTIDIS sponsor H1B visas?
Yes. ARTIDIS filed 1 H1B (LCA) application in FY2026, according to the latest U.S. Department of Labor disclosures. It was for a Executive role.
How much funding has ARTIDIS raised?
ARTIDIS has raised $23.99M in total funding; its latest round was Seed in Oct 2020.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.